Background: Alcohol use (both quantity and dependence) is moderately heritable, and genomewide association studies (GWAS) have identified risk genes in European, African, and Asian populations. The most reproducibly identified risk genes affect alcohol metabolism. Well-known functional variants at the gene encoding alcohol dehydrogenase B and other alcohol dehydrogenases affect risk in European and African ancestry populations. Similarly, variants mapped to these same genes and a wellknown null variant that maps to the gene that encodes aldehyde dehydrogenase 2 (ALDH2) also affect risk in various Asian populations. In this study, we completed the first GWAS for 3 traits related to alcohol use in a Thai population recruited initially for studies of methamphetamine dependence.
I
T IS WELL known that alcohol use disorder (AUD) is moderately heritable (Verhulst et al., 2015) . Genomewide associations studies (GWAS) of alcohol dependence (AD) and habitual alcohol use have been completed in European (Clarke et al., 2017; Gelernter et al., 2014; Jorgenson et al., 2017; Mbarek et al., 2015; Xu et al., 2015) and African (Almli et al., 2017; Gelernter et al., 2014; Jorgenson et al., 2017; Xu et al., 2015) ancestry populations. Work in Asian ancestry populations is more limited, but we have completed a small GWAS in a Chinese population (Quillen et al., 2014) , and other investigators have performed so in Chinese (Yang et al., 2013) , Koreans (Baik et al., 2011; Park et al., 2013) , and Asian Americans (Jorgenson et al., 2017) . The most consistent findings have been associations with variants mapped to genes that encode alcohol metabolizing enzymes -most characteristically variants at alcohol dehydrogenase B (ADH1B) in European and African ancestry subjects (Li et al., 2011) and ALDH2*rs671 (and often ADH1B as well) in Asians (Li et al., 2012) .
Alcohol consumption exacts a huge economic toll in Thailand, estimated to amount to 2% of the gross domestic product as of 2006 (Thavorncharoensap et al., 2010) . However, excepting small candidate gene studies, there have been few studies on alcohol genetics in the Thai population, and to date, no GWAS. One previous study (Assanangkornchai et al., 2003) showed that the aldehyde dehydrogenase 2 (ALDH2) variation is related to hazardous drinking and facial flushing in Thai males. Another study reviewed population genetics of the most relevant alcohol metabolizing enzyme variants in Asians, including Thais (Eng et al., 2007) .
In this study, we completed a GWAS of AD criterion count and the related phenotypes of "MAXDRINKS," or maximum number of alcoholic beverages taken in any 24-hour period over a subject's lifetime (Saccone et al., 2000) , and flushing after drinking alcohol, in a Thai population collected for study of methamphetamine genetics. This was feasible because although the focus in the parent study was on methamphetamine dependence, we used the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA) for assessment. The SSADDA is a comprehensive diagnostic interview designed for genetic studies of substance dependence and related phenotypes (Pierucci-Lagha et al., 2005 . We previously developed a Thai version of the SSADDA, which was translated and validated in genetic studies of opioid dependence in Northern Thailand, where it was shown to have both high interinstrument validity and inter-rater reliability for that trait (Malison et al., 2011 ). There is a high level of comorbidity between methamphetamine dependence and AUDs and a high rate of AUDs in Thailand overall (9.1% in males and 1.0% in females in 2010 (World Health Organization, 2014) , and accordingly, the sample is highly informative for the study of alcoholrelated traits.
MATERIALS AND METHODS

Subject Recruitment and Assessment
We included subjects recruited in 2 stages for studies of the genetics of methamphetamine dependence. For both stages, subjects were recruited at the Princess Mother National Institute on Drug Abuse Treatment (PMNIDAT; formerly Thanyarak Institute) located in Bangkok using similar ascertainment methods (with the main phenotyping assessment via SSADDA (Thai version). Studies were approved by The Faculty of Medicine, Chulalongkorn University Institutional Review Board (Med Chula IRB), the Ethical Review Committee for Research in Human Subjects, Thailand Ministry of Public Health, the Research Committee, Thanyarak Institute on Drug Abuse, and the Yale Human Investigations Committee. Subject characteristics are shown in Table 1 . All subjects provided voluntary written informed consent prior to their research participation and were compensated (500 baht, or roughly US$15), per IRB approval.
Sample 1: Global Screening Array ("GSA"). This stage included methamphetamine users (n = 991) from across Thailand (Table 1) . Subjects were hospitalized for 4 months of residential drug treatment at PMNIDAT from 2007 to 2011 (Kalayasiri et al., 2014) . This initial collection was focused primarily on the genetics of methamphetamine-induced paranoia. Exclusion criteria included including (i) lifetime use of methamphetamines < 11 instances; (ii) history of primary psychotic disorders; and (iii) brain disease (epilepsy, stroke, or brain trauma).
Diagnostic assessments were performed during each subject's rehabilitation by interviewers certified for SSADDA use based on a standard training protocol. Interviews were subjected to a rigorous quality control process, including editing and crossediting by interviewers and final review by the Thai principal investigator (RK).
Sample 2: Multi-Ethnic Global Array ("MEGA"). This stage focused both on severely affected methamphetamine-dependent subjects and subjects who were methamphetamine-exposed but not dependent (n = 589, Table 1 ). Subjects were hospitalized for 4 months of residential drug treatment at PMNIDAT from 2015 to 2017. The primary focus of this ongoing study is the genetics of methamphetamine dependence and related traits (including AD). Interviewers were retrained in the SSADDA in 2015 and either certified or re-certified as needed. Additional interviewers hired over the course of the study also underwent standard training. Subjects were administered the SSADDA, and SSADDA quality control procedures were performed, as for Sample 1.
Phenotypes
Only alcohol-exposed subjects were included. We studied AD (by DSM-IV criterion count), maximum number of alcoholic beverages taken in any 24-hour period over the subject's lifetime (MAX-DRINKS), and flushing. Phenotype definitions were as follows: 1. DSM-IV criterion count was defined as the sum of DSM-IV AD symptoms, up to 7 (AD-CrC). Subjects with missing values for AD criteria were excluded. 2. MAXDRINKS was defined by Thai SSADDA item E4_TotDrnk. Values >100 were set to 100 (to account for inflated and potentially spurious MAXDRINKS estimates) and were log-transformed for analyses. 3. Flushing was defined by Thai SSADDA item E2A_1_BlushA, which translates to: "While drinking, has 1 or 2 drinks of alcohol ever caused you to flush or blush-that is, your face and hands felt hot and your face turned red?" Subjects who answered "yes" were classified as affected, and those answered "no" were classified as unaffected. 
Genotyping and Quality Control
Sample 1 (GSA sample) was genotyped on the Illumina (San Diego, CA) Global Screening Array (GSA). This is a 642,824 marker array with content added to provide good genomic coverage for several global populations, including East Asians. For Sample 1, there was insufficient DNA to allow use of the MEGA array, which has higher DNA input requirements.
Sample 2 (MEGA sample) was genotyped on the Illumina MultiEthnic Global Array (MEGA). This is a 1,779,819 marker array with content added to provide excellent genomic coverage for several global populations, including East Asians. For Sample 1 (GSA), 991 Thai subjects were phenotyped initially. Some DNA was available for 863 of these. Two hundred and fifty-seven subjects were removed due to low genotype call rate (<0.9). (A quality control call rate of 0.95 is preferred, but the quantity and quality of DNA from Sample 1 were poor, so we used a lesser standard; had we used a threshold of 0.95, more than 100 additional subjects would have been removed.) Two subjects were removed due to mismatched genotype and phenotypic sex; 6 subjects were removed due to high heterozygosity rate; 7 were removed because they were duplicates; and 10 were removed because the same subjects were also present in the Sample 2, for which betterquality DNA was available. In total, 581 subjects remained for analysis. Only autosomal single nucleotide polymorphisms (SNPs) were retained. SNPs with low genotype call rate (< 0.95), minor allele frequency (MAF) < 0.01, or Hardy-Weinberg Equilibrium (HWE) p < 10 À6 were removed; 334,631 SNPs remained for imputation.
For Sample 2 (MEGA), the study is ongoing; 589 Thai subjects have been phenotyped to date; 536 of these were genotyped by MEGA array. One subject was removed due to mismatched genotype and phenotypic sex; 1 subject was removed due to low genotype call rate (<0.95); 4 subjects were removed because they were duplicates. Five hundred and thirty subjects remained for analysis. Only autosomal SNPs were retained; SNPs with low genotype call rate (<0.95) MAF < 0.01 or HWE p < 10 À6 were removed; 728,129 SNPs remained for imputation.
Principal Component Analyses
To identify genetic outliers and ascertain concordance with selfreported race, we completed a principal component (PC) analysis on SNPs common to the individual genotyping arrays (pruning by linkage disequilibrium (LD) r 2 > 0.2) and the 1000 Genome phase 3 reference panels (African populations, AFR; admixed American populations, AMR; East Asian populations, EAS; European populations, EUR; and South Asian populations, SAS) using EIGEN-SOFT Price et al., 2006) . Samples 1 and 2 were analyzed separately. We then completed a second PC analysis using Asian populations from the 1000 Genome panels (EAS and SAS), now categorized by specific region, to investigate the finescale population structure of the included Thai samples (Fig. S1) . A third PC analysis was carried out within the Thai samples, and the first 3 PCs were then used to correct for population stratification.
Imputation
Additional SNPs were imputed using IMPUTE2 (Howie et al., 2009 ) and 1000 Genome phase 3 (Auton et al., 2015) Asian reference panels (504 EAS and 489 SAS). GSA and MEGA samples were imputed separately. After imputation, 11,314,818 SNPs in GSA and 11,351,136 SNPs in MEGA were obtained. SNPs with imputation accuracy score ≥ 0.8, MAF ≥ 0.05, and HWE p > 10
À6
were retained for association analyses; 4,683,137 SNPs in GSA and 5,477,977 SNPs in MEGA were analyzed.
Statistical Analysis
We performed logistic regression for the binary trait (flushing) and linear regression for ordinal or continuous traits (AD and MAXDRINKS) on unrelated individuals (IBD < 0.05) using PLINK (Purcell et al., 2007 ). An additive model was used, adjusting for age, sex, and the first 3 PCs.
In instances where multiple SNPs achieved genomewide significance (GWS) in the same region, conditional analyses were performed to identify the lead SNP and to test for the presence of any additional independent signal. For each GWS SNP, we tested the association with the phenotype using age, sex, the first 3 PCs, and each of the other SNPs as covariate. The threshold for statistical significance was 5 9 10
À8
. Analyses were completed in each sample separately and then meta-analyzed.
Polygenic Risk Score
Polygenic risk scores (PRS) of related traits in discovery data sets can be used to test the polygenic effect between those traits and the study trait in the target sample. To our knowledge, there have been few large-cohort GWAS on psychiatric diseases carried out in East Asian populations. The CONVERGE (China, Oxford and Virginia Commonwealth University Experimental Research on Genetic Epidemiology) consortium performed the largest GWAS so far for major depressive disorder (MDD) in more than 10,000 Chinese women (CONVERGE consortium, 2015) . We obtained the relevant summary statistics from this study from the Psychiatric Genomics Consortium website (http://www.med.unc.edu/ pgc/results-and-downloads). Common SNPs between CON-VERGE and our Thai sample were selected for downstream analysis. The summary data of the common SNPs were clumped by LD with r 2 < 0.2, using a 200-kb window. As described previously (International Schizophrenia Consortium et al., 2009), MDD PRS was calculated as the sum of the risk alleles with pvalues less than a threshold (p T ), weighted by the effect sizes. The associations between the constructed MDD PRS and alcoholrelated phenotypes in our Thai cohorts were tested by linear (AD and MAXDRINKS) or logistic (flushing) regression using glm in R, adjusting for age, sex, and the first 3 PCs. Samples 1 and 2 were analyzed separately and then meta-analyzed. Eight p T thresholds (0.00001, 0.0001, 0.001, 0.005, 0.01, 0.05, 0.1 and 0.5) were considered. Multiple test correction for the 8 p T was considered.
RESULTS
All 3 traits-AD-CrC, MAXDRINKS, and flushingshowed GWS association in the total (meta-analyzed) sample with variants near ALDH2, the lead SNPs mapping to an LD block containing rs671 (Table 2, Tables S1-S3 ). The associations differed in statistical significance, as follows: flushing, lead SNP PTPN11*rs143894582; Sample 1 (GSA), 8.33 9 10 À8 ; Sample 2 (MEGA), 2.76 9 10 À8 ; p meta = 2.01 9 10 À14 (Fig. 1) ; MAXDRINKS, lead SNP rs149212747; Sample 1 (GSA), 9.03 9 10 À9 ; Sample 2 (MEGA), 4.59 9 10 À5 ; p meta = 1.61 9 10
À12
; and AD-CrC, lead SNP rs149212747; Sample 1 (GSA), 1.54 9 10 À5 ; Sample 2 (MEGA), 6.96 9 10 À6 ; p meta = 5.80 9 10 À10 (Fig. 2) . The only trait without GWS in either of the separate samples taken individually was AD-CrC-although this trait reached high statistical significance in the meta-analysis. Manhattan and QQ plots for flushing (individual samples) and MAXDRINKS (individual samples and meta-analysis) are shown in Figs S2-S4. Individual-sample level Manhattan and QQ plots for AD-CrC are shown in Fig. S5 . (Rs671 was directly genotyped in both samples. Rs143894582 was imputed in both samples, with imputation score 0.801 in Sample 1 and 0.872 in Sample 2; rs149212747 was also imputed in both samples, with imputation score 0.900 in Sample 1 and 0.968 in Sample 2.) ADH1B Rs1229984 in ADH1B was genotyped directly on both arrays. This marker passed quality control in Sample 2; however, it did not survive quality control in Sample 1. We reimputed the 2-Mb region surrounding rs1229984 in Sample 1 using either AS populations or EAS populations as references, but the imputation quality for rs1229984 did not pass the defined quality threshold (info < 0.8). We thus tested the association between rs1229984 and the alcohol-related traits only in Sample 2; there was an association with AD-CrC at nominal significance (p = 2.72 9 10
À5
). No association with other traits was observed.
PRS Analysis
PRS results are shown in Table 3 . The PRS based on the CONVERGE major depression GWAS (CONVERGE consortium, 2015) was positively associated with AD-CrC (p T = 0.005, N SNPS = 2,410, beta = 0.151, p = 0.019) and MAXDRINKS (p T = 0.001, N SNPS = 654, beta = 0.200, p = 0.047), supporting shared genetic factors (pleiotropy) between alcohol consumption and major depression. These associations do not, however, survive correction for multiple comparisons (i.e., for the 8 p T . thresholds). The major depression PRS was also negatively associated with flushing (p T = 0.001, N SNPS = 654, beta = À0.539, p = 5.00 9 10 À3 ), with the association for flushing remaining significant after multiple-comparison correction.
Conditional Analysis
After controlling for the known association at rs671, there was no independent significant association between rs143894582 and flushing or between rs149212747 and MAXDRINKS. Rs671 showed GWS for AD (p = 4.46 9 10 
DISCUSSION
This study, the first GWAS of alcohol-related traits in a Thai population (n = 1,045 for meta-analysis), adds to the strong literature supporting ALDH2, and most likely functional variant rs671, as protective with respect to alcohol use; and adds novel genetic pleiotropy results. The association was strongest for flushing, next strongest for MAX-DRINKS, then AD-CrC-consistent with the accepted mechanism of action, where rs671 inactivates ALDH2, leading to impaired clearing of acetaldehyde, the toxic first metabolic product of ethanol in its primary metabolic pathway. Presumably, the aversive effect of the flushing reaction acts as a deterrent to ethanol ingestion. Acetaldehyde is directly responsible for the flushing reaction (Harada et al., 1981) . Rs671, a glutamine to lysine substitution (E487K), results in inactivation of the enzyme subunit (Yoshida et al., 1984) . Biochemistry studies-based on ALDH2 activity in liver samples-suggest that the "null" rs671 allele has a nearly dominant effect (Crabb et al., 1989; Lai et al., 2014) ; the heterozygote retains only about 17% enzyme activity compared to common-allele heterozygotes; minor-allele homozygotes had nearly nil measurable enzyme activity. We did not observe a significant association between ADH1B variants and any of the alcohol-related traits, but this may be attributable to lack of power: acceptable genotype data for that locus was available only for Sample 2 (510 subjects), and in that sample, we did observe a nominally significant association (p = 2.72 9 10 À5 ). As acetaldehyde is implicated in various digestive tract cancers as well, these results may be relevant to a range of pathologies beyond AD per se. For example, this same variant is strongly implicated in esophageal cancer (Brooks et al., 2009 ) and head and neck cancers (Chang et al., 2017) . We showed in a previous phenomewide association study (Polimanti et al., 2016 ) that ALDH2 rs671 is also nominally associated with "highest grade finished in school," consistent with findings for ADH1B.
The observations of correlations strictly on the phenotypic level require some explanation. The correlation between AD- CrC and MAXDRINKS is expected: The larger the value for MAXDRINKS, the higher the risk to have more alcohol dependence criteria. The positive correlation between ADCrC and flushing is perhaps more surprising as it is in effect opposite to the genetic relationship between these phenotypes. The most likely explanation for this positive correlation is, we believe, simply that drinking more alcohol causes flushing directly in many subjects. The PRS pleiotropy analyses are congruent with the previously observed genetic overlap between AD and major depression on a population level in European Americans (Andersen et al., 2017) and on a molecular level in African Americans . The observed positive correlation (nominally significant) between depression and MAXDRINKS and negative correlation between depression and flushing are also internally (directionally) consistent with respect to risk. As the analysis used summary statistics from depression to predict the alcohol-related phenotypes, the outsize effect of the ALDH2 region in the latter phenotypes would not be expected to be a major confound; indeed, the most significant association between ALDH2 and major depression in the CONVERGE sample is 0.041 (and the smallest p-value in the 2-Mb region is 0.0049). ALDH2*rs671 is absent from the CONVERGE data set, again supporting that the effect is not driven by that marker. The most likely interpretation of these results is that depression and alcohol-related traits share some of their genetic risk in Asian populations, as has been previously shown in European populations (Andersen et al., 2017; Zhou et al., 2017) . For each of the 3 traits studied, the lead SNP is a variant other than rs671, although presumably the results are mediated by rs671, with its known functional characteristics. Neither of the other lead varints is itself predicted to be functional. And in fact, the lead SNPs are rather distant from rs671, although both are strongly correlated with that variant: rs143894582, lead SNP for flushing, is 665,107 base pairs (bp) from rs671; and rs149212747, lead SNP for AD-CrC and MAXDRINKS, 404,995 bp distant on the other side-a total span of over a megabase. This result most likely reflects random variation in the context of a large effect size in a comparatively small sample and is illustrative of the difficulties commonly faced in identifying the true risk variant from a long associated region. Additionally, rs671 was genotyped directly, but the other lead variants were both imputed. Imperfect imputation could be an additional source of noise obfuscating the signal from rs671. In this case, we know the major risk variant; it is a well-validated and well-known functionally null allele. Without that prior information, these results could have been taken to support distant SNPs mapping to different genes. For MAXDRINKS, the p-value for the lead SNP is over 2 orders of magnitude stronger than that for the putative functional SNP, rs671.
In summary, we present here the first GWAS of AD-CrC, MAXDRINKS, and flushing in a Thai population, confirm a strong relationship between all of these traits and ALDH2, and supply the first findings of pleiotropy between flushing and major depression (and nominally between major depression and alcohol consumption phenotypes) in an Asian population. Prior studies in other, much larger, samples, in different populations, have shown association not only with alcohol metabolizing genes, but with variants mapping elsewhere as well (Clarke et al., 2017; Gelernter et al., 2014; Jorgenson et al., 2017; Schumann et al., 2016) . That we identified strong evidence for association only at and near ALDH2, most likely reflects the limited sample size available to us. When larger Asian samples characterized for AD are available, it is a strong expectation that additional risk loci will be identified. Likewise, the limited pleiotropy results reflect both the sample size limitation in the present study and the lack of other GWAS in Asian populations for comparison purposes.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article: Fig. S1 . Principal compenent analysis for Thai samples. Fig. S4 . Regional Manhattan plot for MAXDRINKS in meta-analysis around ALDH2 locus. Fig. S5 . Individual-sample level Manhattan and QQ plots for alcohol dependence criterion count in GSA (Sample 1) (upper panel) and MEGA (Sample 2) (lower panel). Table S1 . Top findings in meta-analysis for alcohol dependence (p < 1 9 10 À5 ). Table S2 . Top findings in meta-analysis for MAX-DRINKS (p < 1 9 10 À5 ). Table S3 . Top findings in meta-analysis for flushing (p < 1 9 10 À5 ).
